Google News Alert for: heart disease
| CVBT initiates dosing in Phase II coronary heart disease trial Pharmaceutical Business Review - USA ... The Acord trial will include four randomized, double-blind, placebo-controlled doses in approximately 120 patients with severe coronary heart disease. ... See all stories on this topic |
This as-it-happens Google Alert is brought to you by Google.
Create another alert.
Manage your alerts.
没有评论:
发表评论